GLOBAL GLUCOSE MONITORING SYSTEM MARKET FORECAST 2018-2026

  • You are here:
  • Home
  • Reports
  • GLOBAL GLUCOSE MONITORING SYSTEM MARKET FORECAST 2018-2026

GLOBAL GLUCOSE MONITORING SYSTEM MARKET FORECAST 2018-2026

The Global Glucose monitoring system market is separated into Continuous Glucose monitoring system market (CGMS) and Self-monitoring of Blood Glucose (SMBG) market. The CGMS market is anticipated to grow from $ 1120 million in 2017 to $14519.3 million by 2026, at a CAGR of 32.94% between 2018 and 2026 whereas the SMBG market is anticipated to grow from $13192.2 million in 2017 to $24995.5 million by 2026. 

GLOBAL GLUCOSE MONITORING SYSTEM MARKET FORECAST 2018-2026

Glucose Monitoring System (CGMS & SMBG) Market by Component Type (Sensors, Transmitters & Receivers, Insulin Pump) by Application (Home Settings, Diagnostics and Clinics, Hospitals) by Component Type (Test Strips, Glucose Meter) by Application (by Application, Clinics, Hospitals) by Geography

Request free sample

The Global Glucose monitoring system market is separated into Continuous Glucose monitoring system market (CGMS) and Self-monitoring of Blood Glucose (SMBG) market. The CGMS market is anticipated to grow from $ 1120 million in 2017 to $14519.3 million by 2026, at a CAGR of 32.94% between 2018 and 2026 whereas the SMBG market is anticipated to grow from $13192.2 million in 2017 to $24995.5 million by 2026. Continuous Glucose monitoring system (CGM) device is a system used for measuring glucose levels in the interstitial fluid present between the cells of the skin and displaying it on the monitor; whereas Self-monitoring of Blood Glucose (SMBG) refers to the monitoring of glucose level, personally, using SMBG devices available. The Glucose monitoring system market is primarily driven by the following factors:

  • Rise in the incidence of diabetes
  • Increase in healthcare expenditure
  • Increasing focus on research and development
  • Technology integration
  • Increasing CGMS and SMBG affordability
  • Technological advances in GMS devices
  • Awareness among the general population

Glucose Monitoring System

To learn more about this report, request a free sample copy

The important driver increasing growth in the global glucose monitoring system market is the rise in the incidence of diabetes and increase in healthcare expenditure, globally. Changes in lifestyles, eating habits, and reduced physical workout have led to rising obesity, which is the major cause of type 2 Diabetes in adults. The prevalence of type 1 Diabetics has also increased considerably. In 2017, the overall diabetes expenditure came to some 727 billion U.S. dollars; and it is expected to further increase up to nearly 776 billion U.S. dollars during the coming two decades.

The applications of glucose monitoring system market are used extensively for various purposes. Professional CGMS are used by doctors to study the glucose level variations in patients. However, the market for clinical and hospital use of CGMS devices is limited, as these devices are still in the development and approval phase. On the other hand, SMBGs can be used by individuals personally. The frequency of SMBG depends on the type of medical therapy, risk for hypoglycemia, and need for short-term adjustment of therapy. Hospitals are an essential part of areas like treatment, disease diagnosis, disease surveillance programs, perceiving response to treatment, and clinical research. Use of diagnostic techniques helps in early diagnosis, thus enabling appropriate and prompt intervention which reduces the overall disease burden and promotes health.

Hindrance from government regulations and lack of awareness of the diagnostic opportunities are the major factors restraining the glucose monitoring system market. Glucose monitoring system is a highly regulated market. It faces stringent regulations and approval issues from government authorities, especially the U.S FDA. Many diabetologists are also unwilling to use CGM in their practices as explaining the mechanism of this technology to the patients is rather time-consuming. Patients generally have frequent queries about the systems, including aspects like data download, troubleshooting, and interpretation.

The Global Glucose monitoring system market segments include Component types and End users. Their further segmentation is as follows:

  • CGMS market by component type
  • Sensors
  • Transmitters and receivers
  • Insulin pump
  • CGMS market by end users
  • Home settings
  • Diagnostics and clinics
  • Hospitals
  • SMBG market by component type
  • Test Strips
  • Glucose meter
  • Lancets
  • SMBG market by end users
  • Home settings
  • Clinics
  • Hospitals

This report covers the present market conditions and the growth prospects of the global glucose monitoring system market for the forecast years 2018-2026, and considered the revenue generated through the sales of Glucose monitoring system for Components types as well as applications to calculate the market size by considering 2017 as the base year.

Geographically, the global Glucose monitoring system market has been segmented on the basis of five major regions, which include:

The Glucose monitoring system market in North America is expected to hold the largest share by 2026. The U.S is the largest market for the current GMS, as it accounts for 75%-80% of total product revenues. Canada is one of the most developed nations. It has the eighth highest per capita income in the world. People from various races and ethnic groups reside in Canada, which is vastly populated by aboriginal people. On the other hand, the Asia-Pacific market is anticipated to be the fastest-growing region for the Glucose monitoring system market. The last three decades have witnessed an extensive increase in the number of diabetic patients, specifically type 2 diabetes and particularly in developing economies where more than 80% of the people with diabetes live. APAC is an emerging market with significant growth opportunities. APAC has a large unaddressed diabetic patient pool, as the region has densely populated countries. China and India have a large diabetic population, creating opportunities for GMS vendors to meet the market needs for diabetes management. Australia, Japan, and South Korea also have a large potential due to an increased focus on healthcare expenditure.

The Glucose monitoring system market is segmented based on Component types.  CGMS component types are sub-divided into sensors, transmitter & receivers and integrated insulin pumps; whereas the SMBG component types are sub-divided into strips, glucose meter, and lancets. CGMS sensor is used to continuously measure interstitial or blood glucose levels. CGMS sensors are small 9 mm devices, which are inserted into the subcutaneous layer of the abdomen, and are approved to be used for six to seven days. Most of the CGM devices secure transmitter to the skin and the sensor, so that its position is fixed and it doesn’t move around. Integrated insulin pumps are devices with an integrated CGMS. Blood glucose test strips (diabetes test strips) are a key component of blood glucose testing. A glucose meter is a medicinal device for estimating the concentration of glucose in the plasma. The other component type used in Self Glucose monitoring system includes lancets and other small devices. Lancets are designed only to be used once, and then disposed off in a safe way.

The major market players in the global glucose monitoring system market are:

  • ABBOTT
  • DEXCOM
  • TANDEM DIABETES CARE
  • ROCHE DIAGNOSTICS
  • GLYSENS INC

Company Profiles covers analysis of important players.

Abbott Diagnostic, a manufacturer of in vitro diagnostics, offers a range of medical instruments, tests, and systems for clinics and hospitals. Abbott technology also develops manufactures and supply products for the in-vitro diagnostics market. Another company,Glysens is a San Diego based company, that develops Glucose monitoring system devices for the treatment of diabetes. The enrich product portfolio enables and helps to check the blood glucose level, gives automatic warnings when the glucose is at a low level or high level; and also shows historical charts of blood glucose values.

Key Findings of the Global Glucose monitoring system market:

  • CGMS market is anticipated to be a developed market
  • Self-monitoring of blood glucose has huge market opportunity
  • Collaboration of significant companies to develop integrated CGMS-enabled insulin pumps
  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE STUDY MARKET
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
    • BOTTOM-UP APPROACH
    • TOP DOWN APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • CGMS MARKET IS ANTICIPATED TO BE A DEVELOPED MARKET
      • SELF-MONITORING OF BLOOD GLUCOSE HAS HUGE MARKET OPPORTUNITY
      • COLLABORATION OF SIGNIFICANT COMPANIES TO DEVELOP INTEGRATED CGMS-ENABLED INSULIN PUMPS
  1. MARKET OVERVIEW
    • DRIVERS AND IMPACT
      • RISE IN THE INCIDENCE OF DIABETES
      • INCREASE IN HEALTHCARE EXPENDITURE
      • INCREASING FOCUS ON RESEARCH AND DEVELOPMENT
      • TECHNOLOGY INTEGRATION
      • INCREASING CGMS AND SMBG AFFORDABILITY
      • TECHNOLOGICAL ADVANCES IN GMS DEVICES
      • AWARENESS AMONG THE GENERAL POPULATION
    • RESTRAIN AND IMPACT
      • HINDERANCE FROM GOVERNMENT REGULATIONS
      • INADEQUATE REIMBURSEMENT OPTIONS FOR CONTINUOUS GLUCOSE MONITORING DEVICES
      • LACK OF AWARENESS OF THE DIAGNOSTIC OPPORTUNITIES
    • CHALLENGES
      • INTENSE COMPETITION AMONG VENDORS
      • INACCURACY IN READING OF GMS DEVICES
      • INCREASINGLY STRINGENT GOVERNMENT REGULATIONS
  1. CGMS MARKET SEGMENTATION
    • MARKET BY COMPONENT TYPE 2018-2026
      • SENSORS
      • TRANSMITTERS AND RECEIVERS
      • INSULIN PUMP
    • MARKET BY END USERS 2018-2026
      • HOME SETTINGS
      • DIAGNOSTICS AND CLINICS
      • HOSPITALS
  1. SMBG MARKET
  2. SMBG MARKET SEGMENTATION
    • MARKET BY COMPONENT TYPE 2018-2026
      • TEST STRIPS
      • GLUCOSE METER
      • LANCETS
    • MARKET BY END USERS 2018-2026
      • HOME SETTINGS
      • CLINICS
      • HOSPITALS
  1. KEY ANALYTICS
    • PORTER’S 5 FORCE ANALYSIS
      • THREAT OF NEW ENTRANT
      • THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
      • BARGAINING POWER OF BUYERS
      • BARGAINING POWER OF SUPPLIER
      • INTENSITY OF COMPETITIVE RIVALRY
    • MERGER AND ACQUISITIONS
    • KEY BUYING CRITERIA
    • KEY TRENDS
      • DEVELOPMENT OF HIGH-QUALITY WEARABLE DEVICES
      • MOBILE HEALTHCARE MAKING THE DEVICES MORE USER-FRIENDLY
      • INCREASING EFFORTS TOWARDS SPREAD OF AWARENESS
      • INCREASE IN NON-INVASIVE DEVICES
      • ENERGY HARVESTING TECHNOLOGY FOR UNINTERRUPTED USAGE
    • REGULATION OF BLOOD SUGAR
    • INCIDENCE AND PREVALENCE OF DIABETES FOR VARIOUS COUNTRIES
  2. REGIONAL ANALYSIS
    • NORTH AMERICA
      • THE US
        • THE UNITED STATES HEALTH AND HEALTHCARE
        • THE UNITED STATES PHARMACEUTICAL MARKET
      • CANADA
        • CANADA HEALTH AND HEALTHCARE
        • CANADA PHARMACEUTICAL MARKET
        • CANADA DIABETES MARKET
      • EUROPE
        • GERMANY
          • GERMANY HEALTH AND HEALTHCARE
          • GERMANY PHARMACEUTICAL MARKET
        • THE UK
          • THE UNITED KINGDOM HEALTH AND HEALTHCARE
          • THE UNITED KINGDOM HEALTHCARE PROVISION
          • THE UNITED KINGDOM PRIVATE SECTOR INVOLVEMENT
          • THE UNITED KINGDOM PHARMACEUTICALS
        • FRANCE
          • FRANCE HEALTH AND HEALTHCARE
          • FRANCE HEALTHCARE PROVISION
          • MARKET TRENDS
        • ITALY
          • ITALY HEALTH AND HEALTHCARE
          • ITALY HEALTHCARE PROVISION
          • ITALY PHARMACEUTICAL MARKET
        • SPAIN
          • SPAIN HEALTH AND HEALTHCARE
          • SPAIN HEALTHCARE PROVISION
          • SPAIN PHARMACEUTICAL SERVICES
        • RUSSIA
          • RUSSIA HEALTH AND HEALTHCARE
          • RUSSIA PHARMACEUTICAL SERVICES
        • REST OF EUROPE (ROE)
      • ASIA-PACIFIC (APAC)
        • CHINA
          • CHINA HEALTH AND HEALTHCARE
          • CHINA PHARMACEUTICAL MARKET
          • CHINA DIABETES MARKET
          • MARKET TRENDS
        • INDIA
          • INDIA HEALTH AND HEALTHCARE
          • INDIA REGULATORY CHANGES
          • INDIA PHARMACEUTICAL MARKET
          • INDIA DIABETES MARKET
        • AUSTRALIA
          • MARKET TRENDS
        • JAPAN
          • JAPAN HEALTH AND HEALTHCARE
          • JAPAN PHARMACEUTICAL MARKET
          • JAPAN DIABETES MARKET
          • MARKET TRENDS
        • SOUTH KOREA
          • MARKET TRENDS
        • INDONESIA
          • MARKET TRENDS
        • MALAYSIA
          • MARKET TRENDS
        • PHILIPPINES
          • MARKET TRENDS
        • THAILAND
          • MARKET TRENDS
        • VIETNAM
          • MARKET TRENDS
        • REST OF ASIA-PACIFIC (ROAP)
      • LATIN AMERICA
        • BRAZIL HEALTH AND HEALTHCARE
        • BRAZIL PHARMACEUTICAL MARKET
        • MEXICO HEALTH AND HEALTHCARE
        • MEXICO PHARMACEUTICAL MARKET
      • MIDDLE EAST AND AFRICA (MEA)
  1. COMPETITIVE LANDSCAPE
    • MEDTRONIC
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • DEXCOM
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • ABBOTT
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • JOHNSON AND JOHNSON
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • INSULET CORP
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • TANDEM DIABETES CARE
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • ECHO THERAPEUTICS INC
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • ROCHE DIAGNOSTICS
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • NEMAURA MEDICAL INC
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • SENSEONICS INC
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • GLYSENS INC
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • TERUMO
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • WOCKHARDT
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • I-SENS INC
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • MORPEN LABORATORIES LTD.
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVE
      • SCOT ANALYSIS
    • APEX BIOTECHNOLOGY CORP.
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
    • ARKRAY INC
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC ANALYSIS
      • SCOT ANALYSIS
    • B BRAUN MELSUNGEN AG
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC ANALYSIS
    • ASCENSIA
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC ANALYSIS

LIST OF TABLES

TABLE  1      GLOBAL CGMS MARKET BY GEOGRAPHY, 2018-2026($ MILLION)

TABLE  2      GLOBAL SMBG MARKET BY GEOGRAPHY, 2018-2026 ($ MILLION)

TABLE  3      DIABETES PREVALENCE IN VARIOUS GEOGRAPHIES 2015-2040 (MILLIONS)

TABLE  4      GLOBAL CGMS MARKET, BY COMPONENT TYPE, 2018-2026($ MILLION)

TABLE  5      GLOBAL CGMS SENSORS MARKET, BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE  6      GLOBAL CGMS TRANSMITTERS AND RECEIVERS MARKET, BY GEOGRAPHY  2018-2026 ($ MILLION)

TABLE  7      GLOBAL CGMS INSULIN PUMP MARKET, BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE  8      GLOBAL CGMS MARKET, BY END-USER 2018-2026 ($ MILLION)

TABLE  9      GLOBAL CGMS HOME SETTINGS MARKET, BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE  10    GLOBAL CGMS DIAGNOSTICS AND CLINICAL MARKET, BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE  11    GLOBAL CGMS HOSPITAL MARKET, BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE  12    IMPORTANT ASPECTS FOR THE USE OF SMBG DEVICES IN HOME-CARE SETTINGS

TABLE  13    SMBG STRIPS USAGE SCENARIO IN SELECTED COUNTRIES IN AMERICAS

TABLE  14    PRODUCT MATRIX FOR LANCETS

TABLE  15    GLOBAL SMBG MARKET, BY COMPONENT TYPE, 2018-2026 ($ MILLION)

TABLE  16    GLOBAL SMBG LANCETS MARKET, BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE  17    GLOBAL SMBG HOME SETTING MARKET, BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE  18    GLOBAL SMBG CLINICAL MARKET,BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE  19    GLOBAL SMBG HOSPITALS MARKET, BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE  20    GLOBAL SMBG MARKET, BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE  21    GLOBAL CGMS MARKET REVENUE, BY GEOGRAPHY 2018-2026($ MILLION)

TABLE  22    CONVERSION RATE USED FOR DIFFERENT CURRENCIES  INTO DOLLAR

TABLE  23    NORTH AMERICA SMBG MARKET 2018-2026 ($ MILLION)

TABLE  24    NORTH AMERICA CGMS MARKET 2018-2026 ($ MILLION)

TABLE  25    EUROPE SMBG MARKET 2018-2026 ($ MILLION)

TABLE  26    EUROPE CGMS MARKET 2018-2026 ($ MILLION)

TABLE  27    GERMANY DIABETIC  STATISTICS 2015

TABLE  28    AVERAGE PRICES IN GERMANY FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER

TABLE  29    GERMANY SMBG SALES CHANNEL 2018-2026 ($ MILLION)

TABLE  30    AVERAGE PRICES IN UK FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER

TABLE  31    UNITED KINGDOM SMBG SALES CHANNEL 2018-2026 ($ MILLION)

TABLE  32    ASIA-PACIFIC SMBG MARKET REVENUE 2018-2026($ MILLION)

TABLE  33    AVERAGE PRICES IN CHINA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER

TABLE  34    CHINA SMBG SALES CHANNEL 2018-2026 ($ MILLION)

TABLE  35    AVERAGE PRICES IN INDIA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)

TABLE  36    INDIA SMBG SALES CHANNEL 2018-2026 ($ MILLION)

TABLE  37    AVERAGE PRICES IN AUSTRALIA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)

TABLE  38    AUSTRALIA SMBG SALES CHANNEL 2018-2026 ($ MILLION)

TABLE  39    AVERAGE PRICES IN JAPAN FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)

TABLE  40    JAPAN SALES CHANNEL 2018-2026 ($ MILLION)

TABLE  41    AVERAGE PRICES IN SOUTH KOREA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)

TABLE  42    SOUTH KOREA SMBG SALES CHANNEL 2018-2026 ($ MILLION)

TABLE  43    AVERAGE PRICES IN INDONESIA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)

TABLE  44    INDONESIA SMBG SALES CHANNEL 2018-2026 ($ MILLION)

TABLE  45    AVERAGE PRICES IN MALAYSIA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)

TABLE  46    MALAYSIA SMBG SALES CHANNEL 2018-2026 ($ MILLION)

TABLE  47    AVERAGE PRICES IN PHILIPPINES  FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)

TABLE  48    PHILIPPINES SMBG SALES CHANNEL 2018-2026 ($ MILLION)

TABLE  49    AVERAGE PRICES IN THAILAND FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)

TABLE  50    THAILAND SMBG SALES CHANNEL 2018-2026 ($ MILLION)

TABLE  51    AVERAGE PRICES IN VIETNAM FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)

TABLE  52    VIETNAM SMBG SALES CHANNEL 2018-2026 ($ MILLION)

 

 

LIST OF FIGURES 

FIGURE  1    GLOBAL CGMS SENSORS MARKET, 2018-2026($ MILLION)

FIGURE  2    GLOBAL CGMS TRANSMITTERS AND RECEIVERS MARKET, 2018-2026($ MILLION)

FIGURE  3    GLOBAL CGMS INSULIN PUMP MARKET, 2018-2026($ MILLION)

FIGURE  4    GLOBAL CGMS SHARE, BY END-USER 2017 & 2026 (%)

FIGURE  5    GLOBAL CGMS HOME SETTING MARKET, 2018-2026($ MILLION)

FIGURE  6    GLOBAL CGMS DIAGNOSTICS AND CLINICAL MARKET, 2018-2026($ MILLION)

FIGURE  7    GLOBAL CGMS HOSPITAL MARKET, 2018-2026($ MILLION)

FIGURE  8    GLOBAL SMBG MARKET SHARE, BY COMPONENT TYPE 2017 & 2026(%)

FIGURE  9    GLOBAL SMBG TEST STRIPS MARKET, 2018-2026 ($ MILLION)

FIGURE  10  GLOBAL SMBG TEST STRIPS MARKET, BY GEOGRAPHY 2018-2026 ($ MILLION)

FIGURE  11  GLOBAL SMBG GLUCOSE METER MARKET, 2018-2026 ($ MILLION)

FIGURE  12  GLOBAL SMBG GLUCOSE METER MARKET,BY GEOGRAPHY 2018-2026 ($ MILLION)

FIGURE  13  GLOBAL SMBG LANCETS MARKET, 2018-2026 ($ MILLION)

FIGURE  14  GLOBAL SMBG MARKET SHARE, BY END-USER 2017& 2026 (%)

FIGURE  15  GLOBAL SMBG HOME SETTING MARKET, 2018-2026 ($ MILLION)

FIGURE  16  GLOBAL SMBG CLINICAL MARKET, 2018-2026 ($ MILLION)

FIGURE  17  GLOBAL SMBG HOSPITALS MARKET, 2018-2026 ($ MILLION)

FIGURE  18  GLOBAL GGMS MARKET SHARE, BY GEOGRAPHY 2017 & 2026 (%)

FIGURE  19  NORTH AMERICA CGMS MARKET SHARE, BY COUNTRY 2017 & 2026 (%)

FIGURE  20  US CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  21  US SMBG MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  22  CANADA CGMS MARKET REVENUE, 2018-2026 ($ MILLION)

FIGURE  23  CANADA SMBG MARKET REVENUE, 2018-2026 ($ MILLION)

FIGURE  24  EUROPE CGMS MARKET SHARE, BY COUNTRY 2017 & 2026 (%)

FIGURE  25  GERMANY CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  26  GERMANY SMBG MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  27  UK CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  28  UK SMBG MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  29  FRANCE CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  30  FRANCE SMBG MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  31  ITALY CGMS MARKET REVENUE 2018-2026($ MILLION)

FIGURE  32  ITALY SMBG MARKET REVENUE 2018-2026($ MILLION)

FIGURE  33  SPAIN CGMS MARKET REVENUE 2018-2026($ MILLION)

FIGURE  34  SPAIN SMBG MARKET REVENUE 2018-2026($ MILLION)

FIGURE  35  RUSSIA CGMS MARKET REVENUE 2018-2026($ MILLION)

FIGURE  36  RUSSIA SMBG MARKET REVENUE 2018-2026($ MILLION)

FIGURE  37  REST OF EUROPE (ROE) CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  38  REST OF EUROPE (ROE) SMBG MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  39  ASIA-PACIFIC CGMS MARKET REVENUE 2018-2026($ MILLION)

FIGURE  40  CHINA CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  41  CHINA SMBG MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  42  INDIA CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  43  INDIA SMBG MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  44  AUSTRALIA CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  45  AUSTRALIA SMBG MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  46  DEATHS IN AUSTRALIA DUE TO DIABETES

FIGURE  47  JAPAN CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  48  JAPAN  SMBG MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  49  SOUTH KOREA CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  50  SOUTH KOREA SMBG MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  51  INDONESIA CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  52  INDONESIA SMBG MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  53  MALAYSIA CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  54  MALAYSIA SMBG MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  55  PHILIPPINES CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  56  PHILIPPINES SMBG MARKET REVENUE, 2018-2026 ($ MILLION)

FIGURE  57  THAILAND CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  58  THAILAND SMBG MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  59  VIETNAM CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  60  VIETNAM SMBG MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  61  REST OF ASIA-PACIFIC CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  62  REST OF ASIA-PACIFIC SMBG MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  63  LATIN AMERICA CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  64  LATIN AMERICA SMBG MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  65  MEA CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  66  MEA SMBG MARKET REVENUE, 2018-2026($ MILLION)

 

LIST OF FIGURES

FIGURE  1    GLOBAL CGMS SENSORS MARKET, 2018-2026($ MILLION)

FIGURE  2    GLOBAL CGMS TRANSMITTERS AND RECEIVERS MARKET, 2018-2026($ MILLION)

FIGURE  3    GLOBAL CGMS INSULIN PUMP MARKET, 2018-2026($ MILLION)

FIGURE  4    GLOBAL CGMS SHARE, BY END-USER 2017 & 2026 (%)

FIGURE  5    GLOBAL CGMS HOME SETTING MARKET, 2018-2026($ MILLION)

FIGURE  6    GLOBAL CGMS DIAGNOSTICS AND CLINICAL MARKET, 2018-2026($ MILLION)

FIGURE  7    GLOBAL CGMS HOSPITAL MARKET, 2018-2026($ MILLION)

FIGURE  8    GLOBAL SMBG MARKET SHARE, BY COMPONENT TYPE 2017 & 2026(%)

FIGURE  9    GLOBAL SMBG TEST STRIPS MARKET, 2018-2026 ($ MILLION)

FIGURE  10  GLOBAL SMBG TEST STRIPS MARKET, BY GEOGRAPHY 2018-2026 ($ MILLION)

FIGURE  11  GLOBAL SMBG GLUCOSE METER MARKET, 2018-2026 ($ MILLION)

FIGURE  12  GLOBAL SMBG GLUCOSE METER MARKET,BY GEOGRAPHY 2018-2026 ($ MILLION)

FIGURE  13  GLOBAL SMBG LANCETS MARKET, 2018-2026 ($ MILLION)

FIGURE  14  GLOBAL SMBG MARKET SHARE, BY END-USER 2017& 2026 (%)

FIGURE  15  GLOBAL SMBG HOME SETTING MARKET, 2018-2026 ($ MILLION)

FIGURE  16  GLOBAL SMBG CLINICAL MARKET, 2018-2026 ($ MILLION)

FIGURE  17  GLOBAL SMBG HOSPITALS MARKET, 2018-2026 ($ MILLION)

FIGURE  18  GLOBAL GGMS MARKET SHARE, BY GEOGRAPHY 2017 & 2026 (%)

FIGURE  19  NORTH AMERICA CGMS MARKET SHARE, BY COUNTRY 2017 & 2026 (%)

FIGURE  20  US CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  21  US SMBG MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  22  CANADA CGMS MARKET REVENUE, 2018-2026 ($ MILLION)

FIGURE  23  CANADA SMBG MARKET REVENUE, 2018-2026 ($ MILLION)

FIGURE  24  EUROPE CGMS MARKET SHARE, BY COUNTRY 2017 & 2026 (%)

FIGURE  25  GERMANY CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  26  GERMANY SMBG MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  27  UK CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  28  UK SMBG MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  29  FRANCE CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  30  FRANCE SMBG MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  31  ITALY CGMS MARKET REVENUE 2018-2026($ MILLION)

FIGURE  32  ITALY SMBG MARKET REVENUE 2018-2026($ MILLION)

FIGURE  33  SPAIN CGMS MARKET REVENUE 2018-2026($ MILLION)

FIGURE  34  SPAIN SMBG MARKET REVENUE 2018-2026($ MILLION)

FIGURE  35  RUSSIA CGMS MARKET REVENUE 2018-2026($ MILLION)

FIGURE  36  RUSSIA SMBG MARKET REVENUE 2018-2026($ MILLION)

FIGURE  37  REST OF EUROPE (ROE) CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  38  REST OF EUROPE (ROE) SMBG MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  39  ASIA-PACIFIC CGMS MARKET REVENUE 2018-2026($ MILLION)

FIGURE  40  CHINA CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  41  CHINA SMBG MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  42  INDIA CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  43  INDIA SMBG MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  44  AUSTRALIA CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  45  AUSTRALIA SMBG MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  46  DEATHS IN AUSTRALIA DUE TO DIABETES

FIGURE  47  JAPAN CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  48  JAPAN  SMBG MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  49  SOUTH KOREA CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  50  SOUTH KOREA SMBG MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  51  INDONESIA CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  52  INDONESIA SMBG MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  53  MALAYSIA CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  54  MALAYSIA SMBG MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  55  PHILIPPINES CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  56  PHILIPPINES SMBG MARKET REVENUE, 2018-2026 ($ MILLION)

FIGURE  57  THAILAND CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  58  THAILAND SMBG MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  59  VIETNAM CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  60  VIETNAM SMBG MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  61  REST OF ASIA-PACIFIC CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  62  REST OF ASIA-PACIFIC SMBG MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  63  LATIN AMERICA CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  64  LATIN AMERICA SMBG MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  65  MEA CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE  66  MEA SMBG MARKET REVENUE, 2018-2026($ MILLION)

  1. CGMS MARKET SEGMENTATION
    • MARKET BY COMPONENT TYPE 2018-2026
      • SENSORS
      • TRANSMITTERS AND RECEIVERS
      • INSULIN PUMP
    • MARKET BY END USERS 2018-2026
      • HOME SETTINGS
      • DIAGNOSTICS AND CLINICS
      • HOSPITALS
  1. SMBG MARKET SEGMENTATION
    • MARKET BY COMPONENT TYPE 2018-2026
      • TEST STRIPS
      • GLUCOSE METER
      • LANCETS
    • MARKET BY END USERS 2018-2026
      • HOME SETTINGS
      • CLINICS
      • HOSPITALS
  1. REGIONAL ANALYSIS
    • NORTH AMERICA
      • THE US
        • THE UNITED STATES HEALTH AND HEALTHCARE
        • THE UNITED STATES PHARMACEUTICAL MARKET
      • CANADA
        • CANADA HEALTH AND HEALTHCARE
        • CANADA PHARMACEUTICAL MARKET
        • CANADA DIABETES MARKET
    • EUROPE
      • GERMANY
        • GERMANY HEALTH AND HEALTHCARE
        • GERMANY PHARMACEUTICAL MARKET
      • THE UK
        • THE UNITED KINGDOM HEALTH AND HEALTHCARE
        • THE UNITED KINGDOM HEALTHCARE PROVISION
        • THE UNITED KINGDOM PRIVATE SECTOR INVOLVEMENT
        • THE UNITED KINGDOM PHARMACEUTICALS
      • FRANCE
        • FRANCE HEALTH AND HEALTHCARE
        • FRANCE HEALTHCARE PROVISION
        • MARKET TRENDS
      • REST OF EUROPE (ROE)
        • ITALY HEALTH AND HEALTHCARE
        • ITALY HEALTHCARE SYSTEM
        • ITALY PHARMACEUTICAL MARKET
        • SPAIN HEALTH AND HEALTHCARE
        • SPAIN HEALTHCARE PROVISION
        • SPAIN PHARMACEUTICAL SERVICES
    • ASIA-PACIFIC (APAC)
      • CHINA
        • CHINA HEALTH AND HEALTHCARE
        • CHINA PHARMACEUTICAL MARKET
        • CHINA DIABETES MARKET
        • MARKET TRENDS
      • INDIA
        • INDIA HEALTH AND HEALTHCARE
        • INDIA REGULATORY CHANGES
        • INDIA PHARMACEUTICAL MARKET
        • INDIA DIABETES MARKET
        • MARKET TRENDS
      • AUSTRALIA
        • MARKET TRENDS
      • JAPAN
        • JAPAN HEALTH AND HEALTHCARE
        • JAPAN PHARMACEUTICAL MARKET
        • JAPAN DIABETES MARKET
        • MARKET TRENDS
      • SOUTH KOREA
        • MARKET TRENDS
      • INDONESIA
        • MARKET TRENDS
      • MALAYSIA
        • MARKET TRENDS
      • PHILIPPINES
        • MARKET TRENDS
      • THAILAND
        • MARKET TRENDS
      • VIET NAM
        • MARKET TRENDS
      • REST OF ASIA-PACIFIC (ROAP)
    • LATIN AMERICA
      • BRAZIL HEALTH AND HEALTHCARE
      • BRAZIL PHARMACEUTICAL MARKET
      • MEXICO HEALTH AND HEALTHCARE
      • MEXICO PHARMACEUTICAL MARKET
    • MIDDLE EAST AND AFRICA (MEA)

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.